Literature DB >> 8462391

Pupillary abnormalities in type I diabetes occurring during adolescence. Comparisons with cardiovascular reflexes.

J Schwingshandl1, J M Simpson, K Donaghue, M A Bonney, N J Howard, M Silink.   

Abstract

OBJECTIVE: To evaluate computerized infrared pupillometry for the assessment of autonomic neuropathy in adolescents with type I diabetes. RESEARCH DESIGN AND METHODS: We measured resting pupil diameters and pupillary light reflexes in 142 adolescents with type I diabetes (72 boys and 70 girls, 10.4-19.8 yr of age, duration of diabetes 0.7-18.3 yr) and in 75 nondiabetic control subjects (29 boys, 46 girls, 11.3-19.8 yr of age). All study participants were assessed using four standard cardiovascular tests: maximum-minimum heart rate during deep breathing (mean of three cycles); heart-rate change during a Valsalva maneuver (Valsalva ratio, mean of three maneuvers); lying-to-standing heart-rate change (30:15 ratio); and lying-to-standing BP change.
RESULTS: Mean resting pupil diameters were significantly smaller in the diabetic group: 6.28 +/- 0.06 vs. 6.77 +/- 0.11 mm, P < 0.0001); and significantly smaller with greater duration of diabetes (r = -0.29, P = 0.0006) and higher levels of GHb (r = -0.24, P = 0.004). Patients with retinopathy grade 30 or more (Wisconsin 191 grading) had significantly smaller resting pupil diameters: 5.9 +/- 0.16 vs. 6.4 +/- 0.12 mm, P = 0.008). The phasic light reflex as determined by reflex amplitude and maximum constriction velocity was significantly reduced in the diabetic group: 2.27 +/- 0.03 vs. 2.44 +/- 0.04 mm, P = 0.0009; and 6.68 +/- 0.12 vs. 7.24 +/- 0.16 mm/s, P = 0.007). Reduced reflex amplitude was related to a longer postpubertal duration of diabetes (r = -0.18, P = 0.04). We found no association between pupillary and cardiovascular tests.
CONCLUSIONS: Infrared computerized pupillometry demonstrates subclinical diabetic autonomic neuropathy as early as adolescence. Its presence seems to be related to longer duration of diabetes and unfavorable metabolic control.

Entities:  

Mesh:

Year:  1993        PMID: 8462391     DOI: 10.2337/diacare.16.4.630

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  9 in total

1.  Extraesophageal autonomic dysfunction in patients with achalasia.

Authors:  W Olk; B Kiesewalter; P Auer; P Enck; R Kuhlbusch; H J Von Giesen; E Weber; D Häussinger; T Frieling
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

2.  Pupillary autonomic denervation with increasing duration of diabetes mellitus.

Authors:  M Cahill; P Eustace; V de Jesus
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

3.  Disproportionate pupillary involvement in diabetic autonomic neuropathy.

Authors:  Doyle Yuan; Elaine B Spaeth; Steven Vernino; Srikanth Muppidi
Journal:  Clin Auton Res       Date:  2014-11-07       Impact factor: 4.435

4.  The "4A" syndrome: adrenocortical insufficiency associated with achalasia, alacrima, autonomic and other neurological abnormalities.

Authors:  M Gazarian; C T Cowell; M Bonney; W G Grigor
Journal:  Eur J Pediatr       Date:  1995-01       Impact factor: 3.183

5.  Pupil size in diabetes.

Authors:  K Karavanaki; A G Davies; L P Hunt; M H Morgan; J D Baum
Journal:  Arch Dis Child       Date:  1994-12       Impact factor: 3.791

6.  Commentary: Recognizing pupillary dysfunction in diabetic autonomic neuropathy.

Authors:  Padmaja Sudhakar
Journal:  Indian J Ophthalmol       Date:  2019-08       Impact factor: 1.848

7.  A pharmacologic pupillary test in the diagnosis of diabetic autonomic neuropathy.

Authors:  Hee Jung Kwon; Hye Young Kim
Journal:  Korean J Ophthalmol       Date:  2009-12-04

8.  Using System Identification to Construct an Inherent Model of Pupillary Light Reflex to Explore Diabetic Neuropathy.

Authors:  Yung-Jhe Yan; Chien-Nan Chen; Mang Ou-Yang
Journal:  Brain Sci       Date:  2021-06-25

9.  Establishing a normative database for quantitative pupillometry in the pediatric population.

Authors:  Sanket S Shah; Hantamalala Ralay Ranaivo; Rebecca B Mets-Halgrimson; Karen Rychlik; Sudhi P Kurup
Journal:  BMC Ophthalmol       Date:  2020-03-26       Impact factor: 2.209

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.